{"analyses":[{"ciLowerLimit":"0.892","ciNumSides":"TWO_SIDED","ciPctValue":"95","ciUpperLimit":"1.413","groupIds":["OG000","OG001"],"nonInferiorityType":"SUPERIORITY","pValue":"0.3347","paramType":"Hazard Ratio (HR)","paramValue":"1.123","statisticalComment":"Stratified","statisticalMethod":"Log Rank"}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"6.93","upperLimit":"9.72","value":"8.28"},{"groupId":"OG001","lowerLimit":"8.08","upperLimit":"9.46","value":"8.34"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"174"},{"groupId":"OG001","value":"190"}],"units":"Participants"}],"description":"Duration of disease control was defined for each participant with a best response of CR, PR, or stable disease (SD) as the time from randomization to the first date of disease progression or death due to any cause.","dispersionType":"95% Confidence Interval","groups":[{"description":"75 milligrams per meter squared (mg/m\\^2) doxorubicin administered intravenously (IV) on day 1 of each 21 day cycle for 8 cycles plus 20 milligrams per kilogram (mg/kg) dose of olaratumab administered IV on day 1 and day 8 of cycle 1 and 15 mg/kg olaratumab administered IV on day 1 and day 8 of cycles 2-8. Beginning with cycle 9, 15 mg/kg olaratumab administered IV on day 1 and day 8 of each subsequent 21 day cycle until documented progressive disease (PD) or discontinuation for any other reason.","id":"OG000","title":"Doxorubicin + Olaratumab"},{"description":"75 mg/m\\^2 doxorubicin administered IV on day 1 of each 21 day cycle for 8 cycles plus placebo (equivalent volume) administered IV on day 1 and day 8 for 8 cycles. Beginning with cycle 9, placebo (equivalent volume) administered on days 1 and 8 of each subsequent 21 day cycle until PD or discontinuation for any other reason.","id":"OG001","title":"Doxorubicin + Placebo"}],"paramType":"MEDIAN","populationDescription":"All randomized participants who had evaluable DDC data.","reportingStatus":"POSTED","timeFrame":"Date of CR, PR, or SD to Objective Disease Progression or Death Due to Any Cause (Up to 35.8 Months)","title":"Duration of Disease Control (DDC)","type":"SECONDARY","unitOfMeasure":"Months"}